Navigation Links
First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder

whom previous treatments had not worked," said Mr. Prokar Dasgupta, consultant urologist at Guy's Hospital, honorary senior lecturer at King's College London, and a co-principal investigator of the study. "These were patients who were seriously affected by their OAB symptoms. At basline, 81 percent of patients in the botulinum toxin type A treatment group and 67 percent in the placebo treatment group were experiencing urge urinary incontinence daily."

OAB is more common than osteoarthritis or diabetes(1,2) and is estimated to affect 16-17% of the population in the U.S. and Western Europe.(3) In addition, the economic burden of OAB is substantial. In the U.S., for example, the total economic cost of OAB has been estimated at $12 billion in 2000 (including costs incurred in the community and institutions).

About the Study

The double-blind trial included 34 patients with OAB and confirmed IDO who had failed on a trial of anticholinergic therapy for six weeks or more due to either poor efficacy or tolerability. They were randomly assigned to treatment with BTX-A 200 U (BOTOX(R)) (16 patients) or placebo (18 patients). The primary outcome measure was change in maximum cystometric capacity (MCC), a measure of urinary bladder capacity. Secondary outcome measures included changes in OAB symptoms, other measures related to urinary bladder filling and pressure, symptoms of urgency and incontinence, and quality of life (QoL). Patients were assessed at 4 and 12 weeks post-injection, at which point the study was unblinded; BTX-A patients were further followed until 24 weeks.

BTX-A treatment significantly increased MCC vs. baseline at 4 weeks (by about 72%) and 12 weeks (by about 45%), compared to a 15 percent decrease in placebo patients at both time points. The differences between MCC changes for the BTX-A and placebo groups were significant at both time points (p<0.0001 and p<0.0011, respectively). Likewise, at 4 and 12 weeks compared to baseline,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:6/2/2015)... ANGELES , June 2, 2015  CytRx Corporation ... company specializing in oncology, today announced that it has ... pending in the Delaware Court ... the Company,s current and former directors and officers, and ... The lawsuit, captioned In re CytRx Corp. Stockholder ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jrlgdj/electrophysiology ) has ... by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation ... Generator, ICE, X-ray)) & Indication (AF, VT, WPW) ... their offering. The global electrophysiology (EP) ... CAGR of 10.3% from 2014 to 2019 ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 /PRNewswire/ ... principal owner, Ampersand Capital Partners (Ampersand), announced the ... operation of Array BioPharma Inc. (Array).  Accuratus was ... Eagan, MN acquired Microtest ... GLP analytical and microbial testing services to the ...
Breaking Medicine Technology:CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
(Date:6/2/2015)... 2015 ODU , a ... connector solutions and cable assemblies, is announcing its ... the US market. , ODU MINI-SNAP® ... The self- securing circular connector solution is ideal ... require significant customization such as: sensor devices, data ...
(Date:6/2/2015)... 2015 Visiting Nurse Association (VNA) ... home health care, hospice and community services, announced ... Steve Landers, MD, MPH, to the Visiting Nurse ... , VNAA is a national association based in ... driven, nonprofit providers of home and community-based healthcare, ...
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity inspired ... fashion cocktail dresses. The company carries more than 1000 ... suitable for a wide variety of summer events like ... make high quality trendy special occasion dresses ... satin, chiffon and cotton. Their products feature a wide ...
(Date:6/2/2015)... Consumer Reports, the world’s largest and ... commitment to help wipe out antibiotic-resistant bacteria or ... sicken about 2.25 million Americans each year and ... Control and Prevention. , The initiative kicks off ... participating in the White House Forum on Antibiotic ...
(Date:6/2/2015)... Denver, Colorado (PRWEB) June 02, 2015 ... it has tapped Jim Miller to become Amercanex’s ... fully electronic cannabis marketplace in which cultivators, wholesale ... exchange their inventories in a fully transparent intra-state ... and entrepreneur in the financial technology space, helping ...
Breaking Medicine News(10 mins):Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 3Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Amercanex Names Jim Miller to CTO Position 2
... be a cause, expert says, , TUESDAY, July 28 (HealthDay ... a severe shortage of cardiothoracic surgeons at a time when ... procedures that fall under their purview, a new study predicts. ... and delays in care for people needing heart and lung ...
... , , , ... statewide prescription assistance program, announced today that it has partnered with the ... Nevada residents have access to the free drug card program. The Chamber ... work with members to develop additional card distribution sites. , , ...
... Chief Operating ... ... -- CRL Senior Living Communities announced today that Michael Munter, the company,s Chief ... Living Association (WALA) . , , , , ,A seasoned healthcare executive, Munter has strong ...
... , WASHINGTON, July 28 On Tuesday, ... the legislative lobbying arm of Family Research Council, will host ... proposed government takeover of the health care system. FRC Action ... the moral, ethical, and financial dangers of President Obama,s health care ...
... , Seniors Group Calls AARP,s Support of ... , WASHINGTON, July 28 Today the 400,000 ... by President Obama and his Congressional allies that propose to cut ... reform." Thair Phillips, the new president of RetireSafe, said AARP had ...
... 4,500 children in America are diagnosed with leukemia, according to ... the blood, it is the most common cancer in children. ... cases of childhood leukemia, so parents can still be hopeful ... Tel Aviv University,s Sackler School of Medicine and Sheba Medical ...
Cached Medicine News:Health News:Heart Surgeon Shortage Predicted 2Health News:Heart Surgeon Shortage Predicted 3Health News:Michael Munter Named to Wisconsin Assisted Living Association Board 2Health News:RetireSafe Blasts AARP for Supporting Plan to Pay for Health Care on the Backs of Seniors 2Health News:New drug for children with high-risk leukemia 2
Inquire...
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
100L...
Medicine Products: